Patient Guides: ESMO Patient Guides Compilation (France): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 1: Line 1:
{{forpatients}}
{{forpatients}}
Go back to [[France]] page
Go back to [[France]] page
'''Primary purpose:''' To translate complex medical language into understandable information for patients.


'''Sponsor, manager or home institution:''' European Society for Medical Oncology.
'''Sponsor, manager or home institution:''' European Society for Medical Oncology.


'''Primary purpose:''' To translate complex medical language into understandable information for patients.
'''Available guides:'''  


'''Available guides:''' Cancer Treatment During the COVID-19 Pandemic; Immunotherapy Side Effects and Their Management; Personalized Medicine; Survival; Colorectal Cancer; Endometrial Cancer; Stomach Cancer; Gliomas; AML; CML; Follicular Lymphoma; Bone Sarcomas; Non-Small Cell Lung Cancer (NSCLC); Head and Neck Cancer; Soft Tissue Sarcomas.
'''Type of information:''' Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others. [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-french Click here to learn more]
Available guides:
Cancer Treatment During the COVID-19 Pandemic;  
Immunotherapy Side Effects and Their Management;
Personalized Medicine;  
Survival;  
Colorectal Cancer;  
Endometrial Cancer; Stomach Cancer;  
Gliomas;  
AML;  
CML;  
Follicular Lymphoma;  
Bone Sarcomas;  
Non-Small Cell Lung Cancer (NSCLC);  
Head and Neck Cancer;  
Soft Tissue Sarcomas.


'''Type of information:''' Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others.
'''Cancer areas of interest:''' [[hasCancerType::C15-C26: Digestive system cancers]], [[hasCancerType::C51-C58: Female genitalia cancer]], [[hasCancerType::C69-C72: Eye and brain cancer]], [[hasCancerType::C97-C97: Cancers in multiple locations from the start]], [[hasCancerType::C81-C96: Cancers of the blood and immune system]], [[hasCancerType::C40-C41: Bone cancers]], [[hasCancerType::C30-C39: Lung/chest cancers]], [[hasCancerType::C00-C14: Mouth/throat cancers]], and [[hasCancerType::C45-C49: Soft tissue cancer]]. [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-french Click here to learn more].


'''Access to information:''' List of guides [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-french].
'''Access to information:''' [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-french Click here to access].

Revision as of 16:08, 11 May 2024

Go back to France page

Primary purpose: To translate complex medical language into understandable information for patients.

Sponsor, manager or home institution: European Society for Medical Oncology.

Available guides:

Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others. Click here to learn more Available guides: Cancer Treatment During the COVID-19 Pandemic; Immunotherapy Side Effects and Their Management; Personalized Medicine; Survival; Colorectal Cancer; Endometrial Cancer; Stomach Cancer; Gliomas; AML; CML; Follicular Lymphoma; Bone Sarcomas; Non-Small Cell Lung Cancer (NSCLC); Head and Neck Cancer; Soft Tissue Sarcomas.

Cancer areas of interest: C15-C26: Digestive system cancers, C51-C58: Female genitalia cancer, C69-C72: Eye and brain cancer, C97-C97: Cancers in multiple locations from the start, C81-C96: Cancers of the blood and immune system, C40-C41: Bone cancers, C30-C39: Lung/chest cancers, C00-C14: Mouth/throat cancers, and C45-C49: Soft tissue cancer. Click here to learn more.

Access to information: Click here to access.